radiant-3 trial: everolimus in pancreatic neuroendocrine tumors
Published 10 years ago • 583 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
3:35
everolimus in pancreatic neuroendocrine tumors
-
4:38
everolimus and sunitinib in pancreatic neuroendocrine tumors
-
5:52
everolimus in pancreatic neuroendocrine tumors and carcinoid tumors
-
1:35
dr. yao on takeaways from the radiant-3 trial
-
2:01
dr. james yao on everolimus in advanced pancreatic neuroendocrine tumors
-
2:14
dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
-
3:14
everolimus for non-functional neuroendocrine tumours
-
4:20
phase ii study of adjuvant everolimus on pancreatic neuroendocrine tumors of the liver
-
6:00
treatment sequencing and combinations in pancreatic neuroendocrine tumors
-
5:43
targeted therapies for the treatment of nets
-
10:00
case study: treating metastatic pancreatic neuroendocrine tumors
-
9:05
role of somatostatin analogs in pancreatic neuroendocrine tumors
-
3:39
targeted therapies in neuroendocrine tumors
-
5:28
prognostic indicators in pancreatic neuroendocrine tumors
-
7:48
effect of everolimus on markers of angiogenesis in patients with advanced pnet
-
6:01
targeted therapies in pancreatic neuroendocrine tumors
-
7:19
radiant-4: results of international trial show promise in the treatment of neuroendocrine tumours
-
8:00
everolimus octreotide lar in patients with advanced lung nets: analysis from radiant-2
-
7:29
ecc 2015: radiant-4 trial showed promise in the treatment of neuroendocrine tumours